0001104659-24-072817.txt : 20240618
0001104659-24-072817.hdr.sgml : 20240618
20240618161539
ACCESSION NUMBER: 0001104659-24-072817
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240614
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Calais Philippe
CENTRAL INDEX KEY: 0001693728
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40363
FILM NUMBER: 241051976
MAIL ADDRESS:
STREET 1: C/O MARINA BIOTECH, INC.
STREET 2: 17870 CASTLETON STREET, SUITE 250
CITY: CITY OF INDUSTRY
STATE: CA
ZIP: 91748
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Transcode Therapeutics, Inc.
CENTRAL INDEX KEY: 0001829635
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811065054
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6 LIBERTY SQUARE
STREET 2: #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-301-6857
MAIL ADDRESS:
STREET 1: 6 LIBERTY SQUARE
STREET 2: #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
4
1
tm2417512-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-14
0
0001829635
Transcode Therapeutics, Inc.
RNAZ
0001693728
Calais Philippe
C/O TRANSCODE THERAPEUTICS, INC.
6 LIBERTY SQUARE, #2382
BOSTON
MA
02109
1
0
0
0
0
Stock Option (right to buy)
1.20
2024-06-14
4
A
0
70000
0.00
A
2034-06-13
Common Stock
70000
70000
D
Fifty percent (50%) of the shares subject to this option vested and became exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Thomas A. Fitzgerald, as Attorney-in-Fact
2024-06-18